Latest News
BioCardia, Inc.
- Form 4 Biocardia Inc: Peter Altman (Director, President and CEO) For: 15 October
- BioCardia president and CEO Peter Altman buys $475 in BCDA shares
- At $0.95 per share, BioCardia (BCDA) CEO buys 500 shares across two purchases.
- BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter
- FDA accepts BioCardia pre-submission for Helix catheter By Investing.com
- FDA accepts BioCardia's pre-submission for Heli...
- BioCardia: FDA Accepts De Novo Pre-Submission for Helix Catheter; Substantive Review, Meeting Expected This Quarter
- BioCardia Announces FDA Acceptance of Helix Catheter De Novo Pre-Submission for Marketing Clearance
- FDA Accepts BioCardia's De Novo Pre-Submission for Helix Catheter, Review Scheduled This Quarter
- BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting
- BioCardia Completes Revised FDA Pre-Submission for Helix Catheter Under De Novo Pathway
- BioCardia | 4: Statement of changes in beneficial ownership of securities-Officer Altman Peter
Headlines from the last 30 days, linking to the original publishers. See all market news →